• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Differences in NSAID tolerability profiles. Fact or fiction?

作者信息

Skeith K J, Wright M, Davis P

机构信息

Department of Medicine, University of Alberta, Edmonton, Canada.

出版信息

Drug Saf. 1994 Mar;10(3):183-95. doi: 10.2165/00002018-199410030-00001.

DOI:10.2165/00002018-199410030-00001
PMID:8043221
Abstract
摘要

相似文献

1
Differences in NSAID tolerability profiles. Fact or fiction?非甾体抗炎药耐受性特征的差异：事实还是虚构？
Drug Saf. 1994 Mar;10(3):183-95. doi: 10.2165/00002018-199410030-00001.
2
Nongastrointestinal adverse reactions to NSAID.非甾体抗炎药的非胃肠道不良反应。
J Rheumatol Suppl. 1990 Feb;20:42-5.
3
NSAID adverse effects & interactions: who is at risk?
Am Pharm. 1992 Mar;NS32(3):39-47. doi: 10.1016/s0160-3450(15)31182-x.
4
[Side effects of fenamates].[非甾体抗炎芬那酸类药物的副作用]
Therapie. 1976 May-Jun;31(3):325-42.
5
NSAID use in populations at-risk for UGI hemorrhage.
Del Med J. 1998 Jun;70(6):299-300.
6
Haematological side-effects of drugs.
Practitioner. 1976 Jan;216(1291):37-43.
7
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.美国心脏病学会基金会/美国胃肠病学会/美国心脏协会2008年关于降低抗血小板治疗和非甾体抗炎药使用的胃肠道风险的专家共识文件。
Am J Gastroenterol. 2008 Nov;103(11):2890-907. doi: 10.1111/j.1572-0241.2008.02216.x. Epub 2008 Oct 3.
8
Risk factors and current NSAID use.
J Rheumatol. 1999 Jul;26(7):1429-31.
9
Many NSAID users who bleed don't know when to stop.许多出血的非甾体抗炎药使用者不知道何时该停药。
BMJ. 1998 Feb 14;316(7130):492. doi: 10.1136/bmj.316.7130.492.
10
Proton pump inhibitors and risk of upper gastrointestinal bleeding in NSAID users.质子泵抑制剂与非甾体抗炎药使用者上消化道出血风险
Am J Gastroenterol. 2008 Oct;103(10):2658-9. doi: 10.1111/j.1572-0241.2008.02074_9.x.

引用本文的文献

1
Use of nonsteroidal anti-inflammatory drugs and coxibs in the elderly. Are we following the guidelines?老年人使用非甾体抗炎药和昔布类药物。我们遵循指南了吗？
Clin Rheumatol. 2008 Sep;27(9):1081-2. doi: 10.1007/s10067-008-0959-0. Epub 2008 Jul 12.
2
Nonsteroidal anti-inflammatory drugs and heart failure.非甾体抗炎药与心力衰竭
Drugs. 2003;63(6):525-34. doi: 10.2165/00003495-200363060-00001.
3
Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.骨关节炎和类风湿关节炎患者中抗风湿药物的心血管风险概况

本文引用的文献

1
SALICYLATE OTOTOXICITY: A CLINICAL STUDY.水杨酸盐耳毒性：一项临床研究。
N Engl J Med. 1965 Sep 9;273:587-90. doi: 10.1056/NEJM196509092731104.
2
INDOMETHACIN IN RHEUMATIC DISEASE: A CLINICAL ASSESSMENT.吲哚美辛治疗风湿性疾病：临床评估
Med J Aust. 1965 Feb 20;1(8):266-9. doi: 10.5694/j.1326-5377.1965.tb71619.x.
3
Effect of aspirin administration on serum glutamic oxaloacetic and glutamic pyruvic transaminases in children.阿司匹林给药对儿童血清谷草转氨酶和谷丙转氨酶的影响。
Drugs. 2002;62(11):1599-609. doi: 10.2165/00003495-200262110-00003.
4
Analysis of the costs of NSAID-associated gastropathy. Experience in a US health maintenance organisation.非甾体抗炎药相关性胃病的成本分析。美国一家健康维护组织的经验。
Pharmacoeconomics. 1997 Jul;12(1):76-88. doi: 10.2165/00019053-199712010-00008.
5
Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure.非甾体抗炎药对充血性心力衰竭患者的不良心血管影响。
Drug Saf. 1997 Sep;17(3):166-80. doi: 10.2165/00002018-199717030-00003.
6
Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.环氧化酶同工酶。近期研究结果如何影响对非甾体抗炎药的认识
Drugs. 1997 Apr;53(4):563-82. doi: 10.2165/00003495-199753040-00003.
7
Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.酮咯酸。对其药效学、药代动力学特性及在疼痛管理中的治疗应用的重新评估。
Drugs. 1997 Jan;53(1):139-88. doi: 10.2165/00003495-199753010-00012.
8
Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.吡罗昔康-β-环糊精。对其药效学和药代动力学特性以及在风湿性疾病和疼痛状态中的治疗潜力的综述。
Drugs. 1994 Dec;48(6):907-29. doi: 10.2165/00003495-199448060-00007.
Proc Soc Exp Biol Med. 1956 Oct;93(1):84-8. doi: 10.3181/00379727-93-22671.
4
The influence of rheumatic fever on serum concentrations of the enzyme, glutamic oxalacetic transaminase.
Circulation. 1955 Nov;12(5):795-806. doi: 10.1161/01.cir.12.5.795.
5
The toxic effects of phenylbutazone (butazolidin); review of the literature and report of the twenty-third death following its use.
N Engl J Med. 1955 Sep 8;253(10):404-10. doi: 10.1056/NEJM195509082531003.
6
Erythema multiforme bullosum following phenylbutazone therapy.
Ill Med J. 1955 Jan;107(1):37-9.
7
Erythema multiforme bullosum following phenylbutazone treatment for arthritis; report of a fatal case.
AMA Arch Derm Syphilol. 1954 Jun;69(6):674-7. doi: 10.1001/archderm.1954.01540180024003.
8
Stevens-Johnson syndrome and granulocytopenia after phenylbutazone.保泰松致史蒂文斯－约翰逊综合征和粒细胞减少症
Br Med J. 1954 Apr 3;1(4865):795. doi: 10.1136/bmj.1.4865.795.
9
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.非甾体抗炎药对人体小肠和大肠的副作用。
Gastroenterology. 1993 Jun;104(6):1832-47. doi: 10.1016/0016-5085(93)90667-2.
10
Renal toxicity of the nonsteroidal anti-inflammatory drugs.非甾体抗炎药的肾毒性
Annu Rev Pharmacol Toxicol. 1993;33:435-65. doi: 10.1146/annurev.pa.33.040193.002251.